✦ LIBER ✦

123 SIROLIMUS-BASED IMMUNOSUPPRESION IS ASSOCIATED WITH INCREASED SURVIVAL AFTER LIVER TRANSPLANTATION FOR HEPATO-CELLULAR CARCINOMA

✍ Scribed by C. Toso; S. Merani; D. Bigam; J. Shapiro; N. Kneteman

Book ID: 117378211
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 148 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60125-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus-based immunosuppression is ass

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma

✍ Christian Toso; Shaheed Merani; David L. Bigam; A.M. James Shapiro; Norman M. Kn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Liver transplantation is an important treatment option for selected patients with nonresectable hepatocellular carcinoma (HCC). Several reports have suggested a lower risk of posttransplant tumor recurrence with the use of sirolimus and a higher one with calcineurin inhibitors, but the selection of

Sorafenib therapy for hepatocellular car

Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant

✍ Aimee E. Truesdale; Stephen H. Caldwell; Neeral L. Shah; Curtis K. Argo; Abdulla 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 169 KB